Search research articles
Contact Us
Filters
Showing results (121-130 of 125) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 125 results.
Contact in Context
|
August 25, 2025
Potential Process Control Issues With Abatacept
James T Isaacs, Philip J Almeter, Aaron N Hunter, et al.
Contact in Context
|
May 5, 2025
Near-Infrared Spectrometry as a Tool for Screening Meropenem for Quality
James T Isaacs, Philip J Almeter, Aaron N Hunter, et al.
Contact in Context
|
May 22, 2024
Application of Near-Infrared Spectroscopy for Screening of Chlorothiazide Sodium Vials
James T Isaacs, Philip J Almeter, Aaron N Hunter, et al.
Contact in Context
|
December 23, 2024
Potential Process Control Issues with Vasopressin
James T Isaacs, Philip J Almeter, Aaron N Hunter, et al.
Journal of Pharmaceutical Innovation
|
June 9, 2022
FDA Approaches in Monitoring Drug Quality, Forces Impacting the Drug Quality, and Recent Alternative Strategies to Assess Quality in the US Drug Supply
Philip J Almeter, James T Isaacs, Aaron N Hunter, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 125) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 125 results.
Contact in Context
|
August 25, 2025
Potential Process Control Issues With Abatacept
James T Isaacs, Philip J Almeter, Aaron N Hunter, et al.
Contact in Context
|
May 5, 2025
Near-Infrared Spectrometry as a Tool for Screening Meropenem for Quality
James T Isaacs, Philip J Almeter, Aaron N Hunter, et al.
Contact in Context
|
May 22, 2024
Application of Near-Infrared Spectroscopy for Screening of Chlorothiazide Sodium Vials
James T Isaacs, Philip J Almeter, Aaron N Hunter, et al.
Contact in Context
|
December 23, 2024
Potential Process Control Issues with Vasopressin
James T Isaacs, Philip J Almeter, Aaron N Hunter, et al.
Journal of Pharmaceutical Innovation
|
June 9, 2022
FDA Approaches in Monitoring Drug Quality, Forces Impacting the Drug Quality, and Recent Alternative Strategies to Assess Quality in the US Drug Supply
Philip J Almeter, James T Isaacs, Aaron N Hunter, et al.
Page
of 13